Structural basis of streptomycin off-target binding to human mitoribosome

The ribosome in mitochondria regulates cellular energy production, and its deactivation is associated with pathologies and ageing. Inhibition of human mitoribosome can be caused by antimicrobial off-target binding, which leads to clinical appearances. The anti-tuberculosis drug aminoglycoside streptomycin targets the small subunit and was shown to be coupled with a bilateral decreased visual acuity with central scotomas and an altered mitochondrial structure. Previously, we reported mitochondria-specific aspects of translation related to specialties of the human mitoribosome (Aibara et al., 2020). In this Research advance article, we report 2.23-Å resolution structure of the human mitoribosomal small subunit in complex with streptomycin. The structural data reveals new details of the streptomycin interactions, including specific water molecules and metal ions involved in the coordination. The density for the streptose moiety reveals that previously modeled aldehyde group appears as a loosely bound density, and the hydroxyl group is not resolved. The density replacing the aldehyde group is within hydrogen bonding distance of four phosphate groups of rRNA, suggesting that the ribosome-bound streptomycin is likely to be in the hydrated gem-diol form rather than in the free aldehyde form. Since streptomycin is a widely used drug for treatment, the newly resolved fine features can serve as determinants for targeting.